APA (7th ed.) Citation

Bozorgmehr, F., Müller, A., Rawluk, J., Sianidou, M., Chung, I., & Kropf-Sanchen, C. (2023). Immune checkpoint inhibitors in non-small cell lung cancer - when should we dare to stop treatment? Lung cancer, 184, . https://doi.org/10.1016/j.lungcan.2023.107340

Chicago Style (17th ed.) Citation

Bozorgmehr, Farastuk, Annette Müller, Justyna Rawluk, Maria Sianidou, Inn Chung, and Cornelia Kropf-Sanchen. "Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer - When Should We Dare to Stop Treatment?" Lung Cancer 184 (2023). https://doi.org/10.1016/j.lungcan.2023.107340.

MLA (9th ed.) Citation

Bozorgmehr, Farastuk, et al. "Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer - When Should We Dare to Stop Treatment?" Lung Cancer, vol. 184, 2023, https://doi.org/10.1016/j.lungcan.2023.107340.